This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://linked.opendata.cz/resource/drugbank/drug/DB06856/identifier/chemspider/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n4http://linked.opendata.cz/resource/drugbank/drug/DB06856/identifier/pdb/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/resource/drugbank/drug/DB06856/identifier/pubchem-compound/
owlhttp://www.w3.org/2002/07/owl#
n7http://linked.opendata.cz/ontology/drugbank/
n8http://linked.opendata.cz/resource/drugbank/property/
n14http://linked.opendata.cz/resource/drugbank/drug/DB06856/identifier/pubchem-substance/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://linked.opendata.cz/resource/drugbank/drug/DB06856/identifier/drugbank/

Statements

Subject Item
n2:DB06856
rdf:type
n7:Drug
n7:group
experimental
owl:sameAs
n12:DB06856 n13:DB06856
dcterms:title
6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE
adms:identifier
n4:134 n5:445849 n6:393362 n9:DB06856 n14:99443327
n7:IUPAC-Name
n8:271B5894-363D-11E5-9242-09173F13E4C5
n7:InChI
n8:271B589A-363D-11E5-9242-09173F13E4C5
n7:Molecular-Formula
n8:271B5899-363D-11E5-9242-09173F13E4C5
n7:Molecular-Weight
n8:271B5896-363D-11E5-9242-09173F13E4C5
n7:Monoisotopic-Weight
n8:271B5897-363D-11E5-9242-09173F13E4C5
n7:SMILES
n8:271B5898-363D-11E5-9242-09173F13E4C5
n7:Water-Solubility
n8:271B5892-363D-11E5-9242-09173F13E4C5
n7:logP
n8:271B5890-363D-11E5-9242-09173F13E4C5 n8:271B5893-363D-11E5-9242-09173F13E4C5
n7:logS
n8:271B5891-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Acceptor-Count
n8:271B58A0-363D-11E5-9242-09173F13E4C5
n7:H-Bond-Donor-Count
n8:271B58A1-363D-11E5-9242-09173F13E4C5
n7:InChIKey
n8:271B589B-363D-11E5-9242-09173F13E4C5
n7:Polar-Surface-Area--PSA-
n8:271B589C-363D-11E5-9242-09173F13E4C5
n7:Polarizability
n8:271B589E-363D-11E5-9242-09173F13E4C5
n7:Refractivity
n8:271B589D-363D-11E5-9242-09173F13E4C5
n7:Rotatable-Bond-Count
n8:271B589F-363D-11E5-9242-09173F13E4C5
n7:Bioavailability
n8:271B58A6-363D-11E5-9242-09173F13E4C5
n7:Ghose-Filter
n8:271B58A8-363D-11E5-9242-09173F13E4C5
n7:MDDR-Like-Rule
n8:271B58A9-363D-11E5-9242-09173F13E4C5
n7:Number-of-Rings
n8:271B58A5-363D-11E5-9242-09173F13E4C5
n7:Physiological-Charge
n8:271B58A4-363D-11E5-9242-09173F13E4C5
n7:Rule-of-Five
n8:271B58A7-363D-11E5-9242-09173F13E4C5
n7:Traditional-IUPAC-Name
n8:271B5895-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-acidic-
n8:271B58A2-363D-11E5-9242-09173F13E4C5
n7:pKa--strongest-basic-
n8:271B58A3-363D-11E5-9242-09173F13E4C5